Kim YJ - Search Results

1

CCND2 polymorphisms associated with clearance of HBV infection.

Park TJ, Chun JY, Bae JS, Park BL, Cheong HS, Lee HS, Kim YJ, Shin HD. Park TJ, et al. Among authors: kim yj. J Hum Genet. 2010 Jul;55(7):416-20. doi: 10.1038/jhg.2010.36. Epub 2010 Apr 23. J Hum Genet. 2010. PMID: 20414251

2

[Genetic epidemiological study on single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic HBV infection].

Kim YJ, Lee HS. Kim YJ, et al. Korean J Hepatol. 2009 Mar;15(1):7-14. doi: 10.3350/kjhep.2009.15.1.7. Korean J Hepatol. 2009. PMID: 19346781 Review. Korean.

3

Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: systematic review and meta-analysis.

Cho LY, Yang JJ, Ko KP, Park B, Shin A, Lim MK, Oh JK, Park S, Kim YJ, Shin HR, Yoo KY, Park SK. Cho LY, et al. Among authors: kim yj. Int J Cancer. 2011 Jan 1;128(1):176-84. doi: 10.1002/ijc.25321. Int J Cancer. 2011. PMID: 20232388 Review.

4

Antituberculosis drug-induced liver injury in chronic hepatitis and cirrhosis.

Park WB, Kim W, Lee KL, Yim JJ, Kim M, Jung YJ, Kim NJ, Kim DH, Kim YJ, Yoon JH, Oh MD, Lee HS. Park WB, et al. Among authors: kim yj, kim w, kim dh, kim m, kim nj. J Infect. 2010 Oct;61(4):323-9. doi: 10.1016/j.jinf.2010.07.009. Epub 2010 Jul 27. J Infect. 2010. PMID: 20670648

5

Validation of P2/MS and other noninvasive fibrosis scoring systems in the Korean population with nonalcoholic fatty liver disease.

Yu SJ, Kim DH, Lee JH, Chung GE, Yim JY, Park MJ, Kim YJ, Yoon JH, Jang JJ, Lee HS. Yu SJ, et al. Among authors: kim yj, kim dh. Korean J Gastroenterol. 2011 Jan;57(1):19-27. doi: 10.4166/kjg.2011.57.1.19. Korean J Gastroenterol. 2011. PMID: 21258197 Free article.

6

No associations of polymorphisms in ADPRT with hepatitis B virus clearance and hepatocellular carcinoma occurrence in a Korean population.

Lee JS, Kim JH, Park BL, Cheong HS, Koh I, Kim JY, Park TJ, Pasaje CF, Bae JS, Lee HS, Kim YJ, Shin HD. Lee JS, et al. Among authors: kim jy, kim yj, kim jh. Hepatol Res. 2011 Mar;41(3):250-7. doi: 10.1111/j.1872-034X.2010.00772.x. Epub 2011 Jan 30. Hepatol Res. 2011. PMID: 21276153

7

Genetic analysis of complement component 9 (C9) polymorphisms with clearance of hepatitis B virus infection.

Bae JS, Pasaje CF, Park BL, Cheong HS, Kim JH, Park TJ, Kim JY, Lee JS, Koh IS, Lee HS, Kim YJ, Shin HD. Bae JS, et al. Among authors: kim jy, kim yj, kim jh. Dig Dis Sci. 2011 Sep;56(9):2735-41. doi: 10.1007/s10620-011-1657-3. Epub 2011 Mar 5. Dig Dis Sci. 2011. PMID: 21380615

8

Validation of P2/MS for reflecting hepatic fibrosis in patients with hepatocellular carcinoma.

Yu SJ, Lee JH, Chung GE, Lee CH, Cho EJ, Jang ES, Kwak MS, Kim YJ, Yoon JH, Jang JJ, Lee HS. Yu SJ, et al. Among authors: kim yj. Korean J Hepatol. 2010 Dec;16(4):389-96. doi: 10.3350/kjhep.2010.16.4.389. Korean J Hepatol. 2010. PMID: 21415583 Free PMC article.

9

TGFBR3 polymorphisms and its haplotypes associated with chronic hepatitis B virus infection and age of hepatocellular carcinoma occurrence.

Kim JH, Yu SJ, Park BL, Cheong HS, Pasaje CF, Bae JS, Lee HS, Shin HD, Kim YJ. Kim JH, et al. Among authors: kim yj. Dig Dis. 2011;29(3):278-83. doi: 10.1159/000327559. Epub 2011 Aug 9. Dig Dis. 2011. PMID: 21829018

10

Lack of association of RAD51 genetic variations with hepatitis B virus clearance and occurrence of hepatocellular carcinoma in a Korean population.

Pasaje CF, Kim JH, Park BL, Cheong HS, Bae JS, Park TJ, Lee JS, Kim Y, Lee HS, Koh I, Kim YJ, Shin HD. Pasaje CF, et al. Among authors: kim yj, kim y, kim jh. J Med Virol. 2011 Nov;83(11):1892-9. doi: 10.1002/jmv.22122. J Med Virol. 2011. PMID: 21915862

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,073 results

Search Page

Filters